Search details
1.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 21(4): 497-507, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32164906
2.
Maintenance single-agent bevacizumab or observation after first-line chemotherapy in patients with metastatic colorectal cancer: a multicenter retrospective study.
Invest New Drugs
; 31(4): 1035-43, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23417697
3.
Pre-emptive skin toxicity treatment for anti-EGFR drugs: evaluation of efficacy of skin moisturizers and lymecycline. A phase II study.
Support Care Cancer
; 21(6): 1691-5, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23314653
4.
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients.
Front Oncol
; 13: 1125013, 2023.
Article
in English
| MEDLINE | ID: mdl-36895480
5.
Symptom improvement as prognostic factor for survival in cancer patients undergoing palliative care: a pilot study.
Support Care Cancer
; 20(6): 1221-6, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-21688165
6.
Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy.
Support Care Cancer
; 19(8): 1159-64, 2011 Aug.
Article
in English
| MEDLINE | ID: mdl-20552375
7.
Regorafenib-to-trifluridine/tipiracil Versus the Reverse Sequence for Refractory Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Real-life Experience.
Anticancer Res
; 41(5): 2553-2561, 2021 May.
Article
in English
| MEDLINE | ID: mdl-33952483
8.
Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy-a pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord Ovest.
Eur J Cancer
; 139: 81-89, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32979645
9.
Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial.
JAMA Oncol
; 4(4): 529-536, 2018 Apr 01.
Article
in English
| MEDLINE | ID: mdl-29450468
10.
Adjuvant chemotherapy in esophageal cancer.
Rays
; 31(1): 31-5, 2006.
Article
in English
| MEDLINE | ID: mdl-16999373
11.
Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis.
PLoS One
; 11(7): e0157751, 2016.
Article
in English
| MEDLINE | ID: mdl-27442239
12.
Changing monoclonal antibody keeping unaltered the chemotherapy regimen in metastatic colorectal cancer patients: is efficacy maintained?
Springerplus
; 2(1): 185, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-23667824
13.
Evaluation of relapse-free survival in T3N0 colon cancer: the role of chemotherapy, a multicentric retrospective analysis.
PLoS One
; 8(12): e80188, 2013.
Article
in English
| MEDLINE | ID: mdl-24339871
Results
1 -
13
de 13
1
Next >
>>